naltrexone with semaglutide vs. GLP-1 for Drinking Less Combining LDN with Microdosing GLP-1

In this study, once-weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, or 15 mg) were compared to once-daily subcutaneous injections of titrated insulin degludec

Anecdotally, when CVS and migraines coexist, both have been observed to respond to TADs, but at different doses, obliging the physician to increase the amount of the drug, even when symptoms of one of the disorders have disappeared

Extracellular vesicles as an alternative copper-secretion mechanism in bacteria

The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism